Modeling hypothalamic pathophysiology in vitro for metabolic, circadian, and sleep disorders

Trends Endocrinol Metab. 2024 Feb 1:S1043-2760(24)00001-8. doi: 10.1016/j.tem.2024.01.001. Online ahead of print.

Abstract

The hypothalamus, a small and intricate brain structure, orchestrates numerous neuroendocrine functions through specialized neurons and nuclei. Disruption of this complex circuitry can result in various diseases, including metabolic, circadian, and sleep disorders. Advances in in vitro models and their integration with new technologies have significantly benefited research on hypothalamic function and pathophysiology. We explore existing in vitro hypothalamic models and address their challenges and limitations as well as translational findings. We also highlight how collaborative efforts among multidisciplinary teams are essential to develop relevant and translational experimental models capable of replicating intricate neural circuits and neuroendocrine pathways, thereby advancing our understanding of therapeutic targets and drug discovery in hypothalamus-related disorders.

Keywords: cell lines; hypothalamic model; hypothalamus; in vitro models; organoids; pluripotent stem cells.

Publication types

  • Review